This September, Parkinson’s disease researchers made progress in three areas: A blood test that could make diagnosing Parkinson’s easier. A genetic clue that may show why some people’s Parkinson’s gets worse faster. A new treatment being tested to protect brain cells that make dopamine. Here’s what happened, why it matters, and what it means for…
This is the seventh post in a series walking through the emotions of Parkinson’s disease — one at a time, honestly, from the heart. If you missed the earlier posts, you can find them here: Shocked, Afraid, Sad, Angry, Lonely, and Comforted. One of the hardest parts of Parkinson’s isn’t just the symptoms. It’s everything…
This August, researchers made progress in three very different areas: testing a treatment that targets inflammation rather than dopamine, uncovering a new way the Parkinson’s protein alpha-synuclein may damage brain cells, and finding a surprising connection between medication-resistant tremor and how quickly Parkinson’s progresses. Here’s what happened, why it matters, and what it could mean for…
This July, researchers made encouraging progress in three important areas: stem cell therapy, a promising new once-daily medication, and a blood test that may one day help predict who is at greater risk of developing dementia. Here’s what happened, why it matters, and what it could mean for you. 1. Stem Cells Were Put Into the…
In this month’s update, we’re sharing three of the most important discoveries from June—what they are, why they matter, and what they could mean for you. 1. A Gene Therapy Helped the Brain Make Dopamine Again The dream of gene therapy for Parkinson’s is simple: Help your brain make more of the dopamine it’s missing. But…